Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.
about
Chronic beryllium disease, HLA-DPB1, and the DP peptide binding grooveCrystal structure of HLA-DP2 and implications for chronic beryllium diseaseStructural basis of metal hypersensitivityHLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypesStructural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and AutoimmunityT cell recognition of berylliumBeryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen GenerationChronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium diseaseHLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.Linking genetic susceptibility and T cell activation in beryllium-induced disease.An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantageRole of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.
P2860
Q23917120-F1400C2D-7AEB-4094-8E02-2B4E1FA5384BQ24305214-48E574C7-75DD-4A69-ADF9-C2B86A166223Q26853141-C47CDF68-8D76-4DAC-87F2-D873BB0A4F3DQ27485629-70951193-22C6-4169-BFBB-25DA1DFC6F86Q27684560-F096EE5B-E681-40A0-914C-80F5FF75E651Q28393881-97732B71-48B9-489E-846E-09AD114987C1Q28396954-93C84D0F-A5C1-40C8-B744-1A7B5DA74AF3Q28397104-BD2C44D4-383E-4FC1-91BB-0DB327BC24F6Q33530024-2A0307E0-1B40-4068-B12E-E3F1E327F264Q33959944-E2861B0A-8C56-41DB-8E96-80D462B413CAQ34353222-5F934B88-1A16-4C12-A1CF-9AE669562348Q34412690-BBD99E80-CC4F-4EAE-A62B-3375E8865CA1Q35694338-4F8F7D27-7241-47BB-950E-ECDA7F2C08E9Q42084853-14AFAA49-6AC0-47F0-BAF2-AFABD901613BQ44397369-A6517207-7EC6-49D6-9806-2BFA89959963Q44820406-59CB29C4-7B4A-40DA-A8FA-150807EE5E73Q55380359-956F51B1-1A8C-4884-9A9A-01FD25346F91
P2860
Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization of natural pe ...... HLA-DP peptide-binding motifs.
@ast
Characterization of natural pe ...... HLA-DP peptide-binding motifs.
@en
type
label
Characterization of natural pe ...... HLA-DP peptide-binding motifs.
@ast
Characterization of natural pe ...... HLA-DP peptide-binding motifs.
@en
prefLabel
Characterization of natural pe ...... HLA-DP peptide-binding motifs.
@ast
Characterization of natural pe ...... HLA-DP peptide-binding motifs.
@en
P50
P1433
P1476
Characterization of natural pe ...... HLA-DP peptide-binding motifs
@en
P2093
Benito Cañas
P2888
P304
P356
10.1007/S00251-004-0735-5
P407
P577
2004-11-24T00:00:00Z
P6179
1019782773